Physician profile
Javier Rodriguez
NPI 1013059385
$1,509.11
in general payments reported to CMS, 2019-2025
14 companies · $185 in 2025
The $185 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $205 · 2020: $169 · 2021: $220 · 2022: $237 · 2023: $352 · 2024: $141 · 2025: $185.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $678.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $678.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $421.06 | 2020-2025 | Penmenvy |
| Sanofi Pasteur INC. | $254.63 | 2020-2023 | |
| Pfizer INC. | $145.28 | 2023-2024 | |
| Astrazeneca Pharmaceuticals LP | $118.81 | 2023 | Imfinzi |
| Merck Sharp & Dohme LLC | $113.02 | 2019-2025 | |
| Gilead Sciences, INC. | $95.10 | 2022 | |
| Horizon Therapeutics Plc | $78.44 | 2023 | Actimmune |
| Cranial Technologies, INC | $77.40 | 2019-2025 | Doc Band |
| Biocompatibles, INC. | $68.18 | 2019 | |
| Phadia US INC. | $43.26 | 2019-2020 | |
| Abbvie INC. | $32.28 | 2020-2021 | |
| Novo Nordisk INC | $26.26 | 2024 | Saxenda, Wegovy |
| Abbott Laboratories | $23.92 | 2025 | Aveir |
| Lilly USA, LLC | $11.47 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Javier Rodriguez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.